Six Flags insiders bet about $30 million on a falling stock. The rest of the federal record was paperwork.
We ran every monitor on the list. No listed company was suspended or debarred, and most of what turned up was already public. The one fresh signal came from insider filings: three Six Flags insiders kept buying after a large third-quarter loss.
The board
| Monitor | What turned up |
|---|---|
| SAM.gov exclusions | One new firm, a private midwifery practice in Albany, NY (HHS). No listed companies added or removed. |
| Insider trading | FUN cluster buy, about $30.7M. Smaller clusters at EFC, HMH, ITT, RMIX. |
| Federal Register | Dueling ITC patent complaints: Hologic vs. Siemens Healthineers. 11 arms-sale notices, led by Saudi F-35s. |
| Congress trades | 15 House reports since Nov 10. All small; three members sold WBD on Oct 7. |
| ClinicalTrials.gov | About 30 industry trials stopped. Mostly registry updates on old decisions; one Lilly MS drug failed an interim look. |
| NHTSA | New Honda/Acura engine-restart probe (701 complaints); Ford Explorer airbag-burn probe. |
| FDA | Class I device recalls: Tandem Mobi insulin pump, Edwards delivery system, Cardinal Health kits with BD Alaris parts. |
| Justice Department | No False Claims Act settlements with listed companies. |
The one worth reading
Six Flags (FUN): three insiders bought into weakness, and one of them bought big. Between Nov 6 and Nov 10, director Rehan Jaffer bought about $14.9 million of stock, chair Richard Haddrill about $91,000 and general counsel Christopher Bennett about $47,000, at an average near $10.29. Filings through Nov 18 bring the three insiders' cluster to about 2.84 million shares and $30.7 million, at an average near $10.80.
The buying came right after a reported $366 million third-quarter loss. Insiders buying with their own money after bad news is one of the few filing patterns that has historically meant something, but it is not a timing signal, and a single director accounts for almost all of the dollars.
Sources: InsiderPrint · OpenInsider cluster buys · MarketBeat High confidence on the trades
Everything else
Hologic and Siemens Healthineers take their mammography fight to the ITC
Two Section 337 complaints land in Friday's Federal Register. Hologic accuses Siemens Healthineers of infringing patents on mammography systems with focal-spot compensation, including X-ray tubes. Siemens Medical Solutions USA filed its own complaint against Hologic. Each side asks for an exclusion order that would block the other's machines at the border. Hologic is no longer publicly traded, so the listed exposure is Siemens Healthineers, which trades in Germany. The ITC still has to decide whether to open the investigations.
Sources: Hologic complaint notice · Siemens complaint notice High confidence
$27 billion of arms-sale notices, mostly old news
The largest is 48 F-35s and 49 engines for Saudi Arabia, $24.3 billion, with Lockheed Martin (LMT) and Pratt & Whitney (RTX) as contractors. The State Department announced that approval on Sept. 17; the Federal Register notice is a formality. Ukraine's $2.68 billion air-defense package and smaller sales to Australia, Korea, Japan (Boeing), Denmark (Lockheed and Sikorsky), Greece and Argentina fill out the rest.
Sources: Federal Register notice · Breaking Defense, Sept. 2026 High confidence
Congress: small trades, one shared name
Fifteen House members filed periodic transaction reports since Nov 10. Rep. Gilbert Cisneros filed 57 trades; the largest were $50,001 to $100,000. Reps. Steve Cohen, Julie Johnson and Thomas Kean each reported selling Warner Bros. Discovery (WBD) on Oct 7, all in the smallest $1,001 to $15,000 band. Nothing here suggests a concentrated bet.
Source: House Clerk disclosures High confidence
Clinical trials: catching up on decisions already made
Most stopped trials updated this week reflect news investors already had. Gilead's weekly oral HIV regimen trial ended after an FDA clinical hold earlier this year. Karyopharm's lymphoma trial ended after the FDA withdrew that approval in April. The one item we could not find announced elsewhere: Eli Lilly stopped a Phase 2 multiple sclerosis study of LY3541860 because the interim analysis "failed to demonstrate the intended treatment effect." It is too small to matter for LLY.
Sources: ClinicalTrials.gov · Fierce Biotech · HealthTree Medium confidence on what is new
Auto safety and device recalls
NHTSA upgraded its Honda review to an engineering analysis after 701 complaints that 2024–2026 Pilot, Odyssey, Passport, Ridgeline and Acura MDX engines would not restart after auto stop/start. It also opened a preliminary evaluation into burn injuries from side-airbag deployment in 2021–2026 Ford Explorers, and is reviewing whether Waymo's school-bus recall fix works. FDA's latest Class I device recalls include Tandem Diabetes's Mobi insulin pump, an Edwards Lifesciences delivery system, and Cardinal Health kits containing BD Alaris infusion parts. Tandem (TNDM) is the only one small enough for a recall to matter.
Sources: NHTSA investigations · openFDA device recalls High confidence
What we couldn't check
Daily Defense Department contract awards, GAO bid-protest decisions, state WARN layoff notices and the SEC's own site refused our automated requests tonight. We used secondary sources where they existed and will add those feeds back as soon as they open.